Trademark: 79220430
Word
LFB
Status
Registered
Status Code
700
Status Date
Tuesday, September 11, 2018
Serial Number
79220430
Registration Number
5557831
Registration Date
Tuesday, September 11, 2018
Mark Type
4
Filing Date
Tuesday, August 29, 2017
Published for Opposition
Tuesday, June 26, 2018

Trademark Owner History

Classifications
41 Editing and publishing of texts other than advertising texts in the field of health; arranging and providing education, training and instruction, namely, providing classes, seminars, symposiums, congresses, conferences, meetings, educational courses, and workshops in the field of health; organization and conducting of seminars, symposiums, congresses, conferences, meetings, educational courses, and workshops, in the field of health
9 Scientific apparatus and instruments, namely, diagnostic apparatus and instruments for calculating and managing drug penetration parameters, for assessing immune deficiency, for laboratory use; downloadable electronic and digital publications, namely, magazines, newsletters, brochures, articles in the field of health; downloadable instructional and teaching material, namely, software in the field of health; electronic reports featuring results from clinical trials and studies in the field of health; recorded software, namely, software for providing medical information in the field of immunology, haemostasis, intensive care, immune deficiency; computer software for educational and commercial activities, namely, software providing information in the field of health; software applications used with medical diagnostic apparatus to calculate and manage immune deficiency or bleeding; computer software for Websites, Intranet and the Internet, namely, software for training and information of patients and health professionals; downloadable computer software applications in the field of health for calculating and managing drug penetration parameters in the human body
5 Pharmaceutical and veterinary products and preparations for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care; medicines for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care; diagnostic products for medical and veterinary use for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care
35 Retail store services featuring pharmaceutical preparations and products, and medical devices; wholesale retail store services featuring pharmaceutical preparations and products, and medical devices; import and export agencies in the field of pharmaceutical preparations and products, and medical devices; commercial representation, namely, promoting the goods and services of others; sales promotion
44 Medical analysis relating to human blood plasma; sampling, collection and preservation of human blood plasma; providing advice and information in the field of health
10 Medical, veterinary, surgical apparatus and instruments, namely, diagnostic apparatus and instruments in the nature of apparatus for medical diagnostic testing and screening in the field of immunology, haemostasis, intensive care, immune deficiency; apparatus for analysis and diagnosis of disorders or diseases in the field of immunology, haemostasis, intensive care, immune deficiency; medical devices, namely, blood collection kits, disposable cartridge, diagnostic kits consisting primarily of probes, buffers and reagents for use in blood coagulation testing and screening
42 Scientific and technological services as well as research and design services relating thereto, namely, scientific research, product development, design and testing for new product and engineering in the field of health; industrial analysis and research services in the field of health; scientific research services using protein expression platform technology for research and development of pharmaceuticals; scientific research services using protein expression platform technology for manufacturing protein-based therapeutics; medical and scientific research of recombinant protein platform technologies designed to lead to new human vaccines; conducting scientific studies in the field of immunology, haemostasis, intensive care; research and development of new products for others; scientific research for medical purposes in the field of immunology, haemostasis, intensive care; cellular and molecular biology research; testing of pharmaceutical products; conducting clinical trials for others in the field of immunology, haemostasis, intensive care; engineering; advice and assistance in the field of health

Trademark Events
Dec 7, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Nov 9, 2017
Sn Assigned For Sect 66a Appl From Ib
Nov 15, 2017
New Application Office Supplied Data Entered
Nov 21, 2017
Application Filing Receipt Mailed
Dec 4, 2017
Assigned To Examiner
Dec 6, 2017
Non-Final Action Written
Jun 26, 2018
Published For Opposition
Dec 17, 2017
Refusal Processed By Mpu
Dec 17, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jan 19, 2018
Refusal Processed By Ib
May 9, 2018
Teas Response To Office Action Received
May 16, 2018
Assigned To Lie
May 19, 2018
Correspondence Received In Law Office
May 19, 2018
Teas/Email Correspondence Entered
May 21, 2018
Approved For Pub - Principal Register
Jun 6, 2018
Notification Of Notice Of Publication E-Mailed
Mar 5, 2021
New Representative At Ib Received
Apr 3, 2021
Correction Transaction Received From Ib
Apr 15, 2021
Correction From The Ib Examined, No Action Is Needed
Jun 26, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 11, 2018
Registered-Principal Register
Dec 11, 2018
Final Disposition Notice Created, To Be Sent To Ib
Dec 19, 2018
Generic Madrid Transaction Created
Dec 19, 2018
Generic Madrid Transaction Sent To Ib
Mar 15, 2019
Final Decision Transaction Processed By Ib
Apr 9, 2021
New Representative At Ib Received
May 4, 2024
New Representative At Ib Received
Sep 11, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24